The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease (NCT01309061) | Clinical Trial Compass
CompletedNot Applicable
The Effect of Human Adipose Tissue-derived MSCs in Romberg's Disease
South Korea5 participantsStarted 2008-03
Plain-language summary
The purpose of this study is to investigate the efficacy and safety of autologous transplantation of adipose tissue derived mesenchymal stem cells (MSCs) in patient with progressive hemifacial atrophy.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects who understand and sign the consent form for this study.
* Age :18-75, males and females.
* Patients with symptom of hemifacial atrophy but not progress disease.
Exclusion Criteria:
* Patients with currently progressive hemifacial atrophy.
* Women who are pregnant or breast feeding or planning to become pregnant during the study.
* Subjects who don't understand purpose and method for this study.
* Patients with psychical disorder or drug and alcohol addiction.
* Participation in another clinical trial or treatment with a different investigational product within 30 days prior to inclusion in the study.
* Serious pre-existing medical conditions like Cardiovascular Diseases, Renal Diseases, Liver Diseases, Endocrine Diseases, Cancer and Diabetes Mellitus.
* Other pathologic conditions or circumstances that difficult participation in the study according to medical criteria